Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters

Exclusion Criteria

• •1. Patients with alcoholic liver disease, autoimmune liver disease, heretic liver disease, drug induced liver disease,nonalcoholic liver disease or other chronic liver disease
• •2. platelet count \< 80000/L
• •3. prothrombin activity ≤ 60%
• •4. patients with any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the subject